Multiple Sclerosis Treatment Report

www.MultipleSclerosisTreatmentReport.com

fecal microbial transplant

Fecal Microbial Transplantation (FMT) for Relapsing Multiple Sclerosis Patients (MS-FMT)

https://clinicaltrials.gov/ct2/show/NCT04150549

FMT for MS Patients (MS-FMT)

Study Type : Interventional
Estimated Enrollment : 34 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: Fecal Microbial Transplantation for Relapsing Multiple Sclerosis Patients – a Placebo-controlled, Double-blinded, Randomized Trial
Estimated Study Start Date : November 2020
Estimated Primary Completion Date : February 2023
Estimated Study Completion Date : February 2023

A Pilot Study of Oral FMT (Fecal Microbial Transplant) in Subjects With Multiple Sclerosis

https://clinicaltrials.gov/ct2/show/NCT04096443?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14

Condition :   Multiple Sclerosis

Intervention :   Biological: Fecal microbial transplant (FMT)

Sponsors :   Griffin Hospital;   Yale-Griffin Prevention Research Center;   Multiple Sclerosis Treatment Center, Derby, Connecticut

Recruiting

Oral FMT (Fecal Microbial Transplant) in Subjects With Multiple Sclerosis

A Pilot Study of Oral FMT (Fecal Microbial Transplant) in Subjects With Multiple Sclerosis

NCT04096443

Thu, 19 Sep 2019 12:00:00 EDT

First Added: 09/19/19 07:52AM

Back to top